T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Plat-E: an efficient and stable system for transient packaging of retroviruses

S. Morita, T Kojima, Toshio Kitamura · Gene Therapy · 2000 · 1.7K citations

Life Sciences, Biology, Biotechnology +9

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Medicine, Immunology, Oncology +17

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

Pushpa Pandiyan, Lixin Zheng, Satoru Ishihara et al. · Nature Immunology · 2007 · 1.2K citations

Life Sciences, Cell Biology, Immunology +16

IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo

Ronald Palacios, Michael Steinmetz · Cell · 1985 · 719 citations

Life Sciences, Immunology, Molecular Biology +16